Search Results - "Arn, Courtney"
-
1
Tisotumab Vedotin Safety and Tolerability in Clinical Practice: Managing Adverse Events
Published in Journal of the advanced practitioner in oncology (01-03-2023)“…Tisotumab vedotin-tftv, an antibody-drug conjugate indicated for the treatment of adult patients with recurrent or metastatic cervical cancer with disease…”
Get full text
Journal Article -
2
STRATEGIES FOR COLLABORATIVE MANAGEMENT OF OCULAR ADVERSE EVENTS OF ELAHERE™ (MIRVETUXIMAB SORAVTANSINE) IN PATIENTS WITH FOLATE RECEPTOR ALPHA (FRa)-POSITIVE RECURRENT OVARIAN CANCER
Published in Oncology nursing forum (01-03-2023)“…Antibody-drug conjugate (ADC) therapies are associated with differentiated toxicity profiles. Mirvetuximab soravtansine (MIRV) is a folate receptor alpha…”
Get full text
Journal Article